Literature DB >> 25126361

The hickory project: controlling healthcare costs and improving outcomes for diabetes using the asheville project model.

Barry A Bunting1, Grover Lee2, Grant Knowles3, Christine Lee4, Paul Allen5.   

Abstract

BACKGROUND: The results of the Asheville Project have shown the success of a community-based, chronic disease management model in improving clinical outcomes in patients with chronic disease while reducing annual costs of care per participant. The question arose whether other programs using a similar management model and implemented in other communities could replicate the success of the Asheville Project in improving clinical outcomes and reducing costs for patients with a chronic disease.
OBJECTIVE: To assess the long-term clinical and financial outcomes of a chronic care management model for patients with diabetes, using the Asheville care management model that was successful in the management of several chronic diseases. STUDY
DESIGN: Longitudinal, 3-year (2007-2009), quasi-experimental, multisite, pre-/postenrollment study.
METHODS: Self-insured health plan members with diabetes agreed to meet on a regular basis (ie, an average of every 3 months) with a healthcare professional. Participants received reduced copayments on diabetes-related medications and supplies as an incentive for participating in the study. Providers utilized a web-based electronic medical record system that provided updated medical and prescription data and highlighted gaps in care based on national standards. Program providers included community pharmacists, population health management company pharmacists, and nurses at on-site clinics, trained in use of evidence-based guidelines of care. Providers assessed patients' medications, knowledge level, and lifestyle; provided patient education and goal setting; and referred patients for physician follow-up and recommendations to physicians. The majority of the encounters were face-to-face.
RESULTS: The study included 95 plan members in the clinical cohort participating for 1 year or more, and 54 members in the financial cohort who have been participating in the program for 3 years. At the end of 3 years, the percentages of those achieving guideline goals increased from baseline to the latest follow-up included, respectively, reaching target hemoglobin A1c levels, 38% to 53%; low-density lipoprotein cholesterol, 46% to 67%; systolic blood pressure (BP), 55% to 72%; diastolic BP, 60% to 71%; annual eye examination, 37% to 61%; and self-testing blood glucose, 79% to 97%. Total healthcare costs decreased by an average of $2704 per participant per year. The program's return on investment was $4.89 to every $1 spent (including program costs).
CONCLUSION: The Hickory Project shows that it is possible to produce sustained improvements in clinical outcomes and reductions in healthcare costs for patients with diabetes using a chronic care model that provides frequent patient follow-up, a focus on appropriate medication therapy, adherence to clinical practice guidelines, and a reduction in prescription copayments for antidiabetes medications as an incentive for patients to participate in the program.

Entities:  

Year:  2011        PMID: 25126361      PMCID: PMC4105733     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  10 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  The Hickory Project builds on the Asheville Project--an example of community-based diabetes care management.

Authors:  Grover C Lee; Thad Mick; Thanh Lam
Journal:  J Manag Care Pharm       Date:  2007 Jul-Aug

3.  The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program.

Authors:  Daniel G Garrett; Leslie A Martin
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

4.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Barry A Bunting; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

5.  An overview of cardiovascular disease burden in the United States.

Authors:  George A Mensah; David W Brown
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

6.  Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes.

Authors:  Daniel G Garrett; Benjamin M Bluml
Journal:  J Am Pharm Assoc (2003)       Date:  2005 Mar-Apr

7.  The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma.

Authors:  Barry A Bunting; Carole W Cranor
Journal:  J Am Pharm Assoc (2003)       Date:  2006 Mar-Apr

8.  Diabetes Ten City Challenge: final economic and clinical results.

Authors:  Toni Fera; Benjamin M Bluml; William M Ellis
Journal:  J Am Pharm Assoc (2003)       Date:  2009 May-Jun

9.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.

Authors:  Barry A Bunting; Benjamin H Smith; Susan E Sutherland
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

Review 10.  Economic costs of diabetes in the U.S. In 2007.

Authors: 
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

  10 in total
  7 in total

1.  From asheville to hickory: transforming our "sick care" system into a true "health care" model.

Authors:  Daniel G Garrett
Journal:  Am Health Drug Benefits       Date:  2011-09

2.  Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer.

Authors:  Nicole D White; Thomas L Lenz; Maryann Z Skrabal; Jessica J Skradski; Louis Lipari
Journal:  Am Health Drug Benefits       Date:  2018-06

Review 3.  The role of the pharmacist in the management of type 2 diabetes: current insights and future directions.

Authors:  Jeffery David Hughes; Yosi Wibowo; Bruce Sunderland; Kreshnik Hoti
Journal:  Integr Pharm Res Pract       Date:  2017-01-16

4.  Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring.

Authors:  Timothy P Ryan; Ryan D Morrison; Jeffrey J Sutherland; Stephen B Milne; Kendall A Ryan; J Scott Daniels; Anita Misra-Hebert; J Kevin Hicks; Eric Vogan; Kathryn Teng; Thomas M Daly
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 5.  Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review.

Authors:  Suan Ee Ong; Joel Jun Kai Koh; Sue-Anne Ee Shiow Toh; Kee Seng Chia; Dina Balabanova; Martin McKee; Pablo Perel; Helena Legido-Quigley
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 6.  Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review.

Authors:  Suzete Costa; Maria Rute Horta; Rita Santos; Zilda Mendes; Isabel Jacinto; José Guerreiro; Maria Cary; Ana Miranda; Dennis K Helling; Ana Paula Martins
Journal:  J Pharm Policy Pract       Date:  2019-03-21

7.  Regional Variation in Pharmacist Perception of the Financial Impact of Medicare Part D.

Authors:  Shamima Khan; Joshua J Spooner; Harlan E Spotts
Journal:  Pharmacy (Basel)       Date:  2018-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.